# PharmExec

> PharmExec - Healthcare Publication

- Base URL: https://www.pharmexec.com
- Generated: 2026-09-22T08:33:19.290Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.pharmexec.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.pharmexec.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.pharmexec.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.pharmexec.com/robots.txt](https://www.pharmexec.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Content Engagement Hubs](https://www.pharmexec.com/content-engagement-hubs)
- [Country Reports](https://www.pharmexec.com//topic/country-reports)
- [Editorial Podcasts](https://www.pharmexec.com/editorial-podcasts)
- [Editorial Videos](https://www.pharmexec.com/editorial-videos)
- [Events](https://www.pharmexec.com/events)
- [Front & Center](https://www.pharmexec.com/front-center)
- [News](https://www.pharmexec.com/news)
- [Pharma Pulse](https://www.pharmexec.com/pharma-pulse)
- [Profiles in Medicine](https://www.pharmexec.com/profiles-in-medicine)
- [Sponsored Content](https://www.pharmexec.com/sponsored-content)
- [Sponsored Podcasts](https://www.pharmexec.com/sponsored-podcasts)
- [Sponsored Videos](https://www.pharmexec.com/sponsored-videos)
- [Topic](https://www.pharmexec.com/topic)
- [Video Series](https://www.pharmexec.com/video-series)
- [Webcasts](https://www.pharmexec.com/webcasts)
- [Whitepapers](https://www.pharmexec.com/whitepapers)

## Featured Content

- [Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic](https://www.pharmexec.com/view/daily-abbvie-ai-powered-drug-discovery-partnership-lambic): AbbVie partners with Iambic on AI-driven drug discovery as Telix Pharmaceuticals moves to acquire ITM Isotope Technologies in a multibillion-dollar ra...
- [Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ](https://www.pharmexec.com/view/-abbvie-lambic-ai-drug-discovery-telix-merges-itm): AbbVie partners with Iambic to deploy its AI molecular superintelligence platform, while Telix Pharmaceuticals agrees to acquire radioisotope leader I...
- [CagriSema Tops Eli Lilly's Tirzepatide for Weight Loss in Late-Stage Diabetes Trial: Report ](https://www.pharmexec.com/view/cagrisema-tops-eli-lilly-tirzepatide-weight-loss-diabetes-trial): Novo Nordisk reports that CagriSema delivered 12.4% average weight loss in a late-stage diabetes trial, outperforming tirzepatide's 9.1% at comparable...
- [How Clinical Data Layers Impact How Patient Availability is Determined](https://www.pharmexec.com/view/clinical-data-layers-impact-patient-availability-determined): Inovalon's Jen Lamppa on how real-time clinical data feeds validate patient eligibility at enrollment — reducing burden while improving accuracy.
- [Approaches and Considerations for Effectuating Maximum Fair Prices (MFPs)](https://www.pharmexec.com/view/approaches-and-considerations-for-effectuating-maximum-fair-prices-mfps): Webinar Date/Time: Tue, Oct 13, 2026 11:00 AM EDT
- [Pharmaceutical Executive Daily: FDA Approves Fayuvi](https://www.pharmexec.com/view/-daily-fda-approves-fayuvi): FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience p...
- [Omnideployment: The Future of Pharmaceutical Commercialization](https://www.pharmexec.com/view/omnideployment-the-future-of-pharmaceutical-commercialization): Omnichannel is no longer enough. Learn how omnideployment integrates AI, content, digital marketing and field engagement into a single accountable sys...
- [Beyond AI-Enabled: Why a New Partner Model is Vital for Pharmaceutical Marketing in Europe](https://www.pharmexec.com/view/beyond-ai-enabled-why-a-new-partner-model-is-vital-for-pharmaceutical-marketing-in-europe): Being AI-enabled is no longer enough. Learn how AI-native commercialization partners can help pharmaceutical companies orchestrate intelligence across...
- [Beyond the Data: Why Scientific Storytelling Will Define the Future of Medical Communications](https://www.pharmexec.com/view/beyond-the-data-why-scientific-storytelling-will-define-the-future-of-medical-communications): Scientific storytelling is becoming a critical differentiator in Medical Affairs. Discover how leading organizations are moving beyond standalone asse...
- [From Direct-to-Patient to Direct-to-Disease: New Commercialization Models in Europe](https://www.pharmexec.com/view/from-direct-to-patient-to-direct-to-disease-new-commercialization-models-in-europe): The future of commercialization extends beyond product promotion and patient acquisition. Learn how Direct-to-Disease models enable pharmaceutical com...

## Feeds and Indexes

- [RSS Feed](https://www.pharmexec.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.pharmexec.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.pharmexec.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.pharmexec.com/authors): Browse all contributors and their published work